Haloperidol: a quarter century of experience.
Research on haloperidol's pharmacokinetics, side effects, indications, and efficacy is reviewed. Issues related to high-dose therapy, rapid neuroleptization, intravenous administration, use in geriatric patients, and coadministration with lithium in mania are discussed. Overall, 25 years of experience have indicated that haloperidol can be used safely and effectively to manage a variety of psychiatric illnesses, so long as dosage and method of administration are adjusted to individual patients' needs. Research continues on the use of this drug, not only in psychiatry but in several other areas of medical practice.
D000368:Aged; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001714:Bipolar Disorder / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004304:Dosage Forms; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D005260:Female; D005334:Fever / Q000139:chemically induced; D006220:Haloperidol / Q000009:adverse effects / Q000266:history* / Q000627:therapeutic use; D049673:History, 20th Century; D006801:Humans; D007700:Kinetics; D008094:Lithium / Q000627:therapeutic use; D016651:Lithium Carbonate; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D004304:Dosage Forms; D016651:Lithium Carbonate; D008094:Lithium; D006220:Haloperidol